SEC Wants Asset Info From Taro Pharma Exec, Sons

By Elaine Meyer (June 28, 2010, 1:08 PM EDT) -- The U.S. Securities and Exchange Commission is demanding that imprisoned former Taro Pharmaceuticals Ltd executive Zvi Rosenthal, who was hit with millions of dollars in civil penalties for his alleged role in an insider trading scheme, turn over information about assets the SEC believes were distributed to Rosenthal's sons, or face court sanctions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!